A Janus G3 Automated Workstation at the Cancer Genomics Research Laboratory, one of the instruments used to conduct the TypeSeq assay.

FREDERICK, Md. -- Scientists at the Frederick National Laboratory for Cancer Research, the National Cancer Institute, and other collaborating institutions have demonstrated that their recently developed technique for detecting human papillomavirus (HPV) in patient samples performs comparably to existing gold-standard methods.

David Pan watches the Vaccine, Immunity, and Cancer Program’s robot that performs automated testing for anti-HPV antibodies.

FREDERICK, Md. -- Ligia Pinto, Ph.D., sees science as a way to change lives and help people in need—and that is precisely what a study recently co-authored by her team at the Frederick National Laboratory for Cancer Research and collaborators at the H. Lee Moffitt Cancer Center and Research Institute and Weill Cornell Medicine holds promise to do.

Pages